Table 3.
Between-patients evaluation of bone mineral density and pain evolution from baseline (T0) to follow-up visit (T1) according to treatment subgroups.
| Alendronate (A) vs Denosumab (D) | ||||||
|---|---|---|---|---|---|---|
| T0A | T0D | p-value | T1A | T1D | p-value | |
| Femoral T-score | -1.07 | -1.35 | 0.44 | -0.98 | -1.39 | 0.19 |
| Lumbar spine T-score | -1.60 | -2.26 | 0.06 | -1.45 | -1.52 | 0.74 |
| NRS | 4.76 | 3.88 | 0.1 | 4.36 | 3.52 | 0.11 |
NRS, number rating scale.